Ruxolitinib for Adult T-Cell Leukemia

Stopped The adult T-cell leukemia (ATL) research program was terminated after the death of the T-cell malignancy group Lead investigator.

Conditions

• T Cell Leukemia, Adult
• Leukemia, Adult T-Cell
• T Cell Leukemia, HTLV I Associated

Interventions

• DRUG: Ruxolitinib
• DRUG: Ruxolitinib
• DRUG: Ruxolitinib
• DRUG: Ruxolitinib

Sponsor

National Cancer Institute (NCI)